![Matthias Schroff](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Matthias Schroff
Amministratore Delegato presso Inceptor Bio LLC
Profilo
Matthias G.
Schroff is currently the Chief Executive Officer at Inceptor Bio LLC since 2023 and the Chief Operating Officer at Exicure Operating Co. since 2018.
Previously, he served as the Chief Executive Officer at Vaximm AG from 2016 to 2017, the President, Chief Executive Officer & Director at Exicure, Inc. from 2018 to 2023, and a Member-Executive Board at MOLOGEN AG from 2005 to 2015.
He also served as a Member-Supervisory Board at Verband Forschender Arzneimittelhersteller eV.
Dr. Schroff obtained his undergraduate degree from the University of Hannover and his doctorate degree from Freie Universität Berlin.
Posizioni attive di Matthias Schroff
Società | Posizione | Inizio |
---|---|---|
Exicure Operating Co.
![]() Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Exicure Operating Co. operates as a biopharmaceutical company commercializing spherical nucleic acid constructs as gene regulation and modulation agents for diseases including applications in oncology, dermatology, neurology, and for immune disorders. The SNA constructs allow the use of oligonucleotide-based therapies to treat diseases in a range of tissue types. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL. | Direttore operativo | 01/04/2018 |
Inceptor Bio LLC
![]() Inceptor Bio LLC BiotechnologyHealth Technology Inceptor Bio LLC operates as a biotechnology industry company. The company is headquartered in Raleigh, NC. | Amministratore Delegato | 08/05/2023 |
Precedenti posizioni note di Matthias Schroff
Società | Posizione | Fine |
---|---|---|
EXICURE, INC. | Amministratore Delegato | 26/04/2023 |
Vaximm AG
![]() Vaximm AG Miscellaneous Commercial ServicesCommercial Services Vaximm AG provides active immunotherapies for patients suffering from cancer. It develops and provides vaccines for patients suffering from cancer. The firmalso provides research, development, manufacture, marketing and sale of pharmaceutical products. The company was founded in September 2008 and is headquartered in Basel, Switzerland. | Amministratore Delegato | 31/12/2017 |
MOLOGEN AG | Amministratore Delegato | 01/11/2015 |
Verband Forschender Arzneimittelhersteller eV
![]() Verband Forschender Arzneimittelhersteller eV Miscellaneous Commercial ServicesCommercial Services Verband Forschender Arzneimittelhersteller eV, founded in 1994, is an association of researching pharmaceutical companies in Germany. The private company is based in Berlin, Germany. The German company's main focus is on the drugs and therapies currently being researched in the industry. | Direttore/Membro del Consiglio | - |
Formazione di Matthias Schroff
Freie Universität Berlin | Doctorate Degree |
University of Hannover | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
MOLOGEN AG | Commercial Services |
EXICURE, INC. | Health Technology |
Aziende private | 4 |
---|---|
Verband Forschender Arzneimittelhersteller eV
![]() Verband Forschender Arzneimittelhersteller eV Miscellaneous Commercial ServicesCommercial Services Verband Forschender Arzneimittelhersteller eV, founded in 1994, is an association of researching pharmaceutical companies in Germany. The private company is based in Berlin, Germany. The German company's main focus is on the drugs and therapies currently being researched in the industry. | Commercial Services |
Vaximm AG
![]() Vaximm AG Miscellaneous Commercial ServicesCommercial Services Vaximm AG provides active immunotherapies for patients suffering from cancer. It develops and provides vaccines for patients suffering from cancer. The firmalso provides research, development, manufacture, marketing and sale of pharmaceutical products. The company was founded in September 2008 and is headquartered in Basel, Switzerland. | Commercial Services |
Exicure Operating Co.
![]() Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Exicure Operating Co. operates as a biopharmaceutical company commercializing spherical nucleic acid constructs as gene regulation and modulation agents for diseases including applications in oncology, dermatology, neurology, and for immune disorders. The SNA constructs allow the use of oligonucleotide-based therapies to treat diseases in a range of tissue types. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL. | Health Technology |
Inceptor Bio LLC
![]() Inceptor Bio LLC BiotechnologyHealth Technology Inceptor Bio LLC operates as a biotechnology industry company. The company is headquartered in Raleigh, NC. | Health Technology |
- Borsa valori
- Insiders
- Matthias Schroff